Vancouver Drug Users Study: Evaluating the Natural History of Injection Drug Use
温哥华吸毒者研究:评估注射吸毒的自然史
基本信息
- 批准号:9060043
- 负责人:
- 金额:$ 9.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-03-01 至 2019-11-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcuteAddressAdultAreaBasic ScienceBehavioralBioinformaticsBiologicalBritish ColumbiaCanadaCaringCessation of lifeCitiesCohort StudiesCrack CocaineDataDevelopmentDrug resistanceDrug usageDrug userEnrollmentEnvironmentEnvironmental Risk FactorEpidemicEthnographyEvaluationEventEvolutionFundingGeneticGrowthHIVHIV SeropositivityHIV riskHealthcareHeroinHome environmentIllicit DrugsImmunologicsIncidenceIndividualInfectionInjecting drug userInjection of therapeutic agentInsuranceInterventionInvestigationLinkMarketingMedicalMethamphetamineMethodsModelingMorbidity - disease rateNational Institute of Drug AbuseNatural HistoryNorth AmericaOverdoseParticipantPeer ReviewPersonsPharmaceutical PreparationsPhylogenetic AnalysisProvincePublic HealthPublicationsRandomized Controlled TrialsRecruitment ActivityRelapseResearchResearch InfrastructureResearch PersonnelRiskRisk BehaviorsRunningSchemeShapesSiteSpecimenSurveysTestingTimeTreatment outcomeVirusWorkYouthaddictionadministrative databaseadolescent drug usebasecareerclinical epidemiologycohortcost effectivenessdevelopment policyexperienceglobal healthhigh riskinjection drug useinnovationmathematical modelmembermethamphetamine usemortalitymultidisciplinarynon-drugnovelprescription opiateprescription opioid misuseprogramspublic health relevancerepositoryresistant strainsocialtraffickingtransmission processtrend
项目摘要
DESCRIPTION: This application proposes novel investigations of the natural history of injection drug use, from initiation to cessation or death, as well as studies of trends in morbidity and mortality. We propose to undertake this work in Vancouver, Canada, where the steady growth in prescription opiate (PO) misuse has become a growing concern. Accordingly, we also seek to evaluate the impact of PO misuse on the natural history of injection drug use in an environment with an active heroin market, including the impact of PO use on injecting initiation and cessation, HIV risk behavior and overdose. We also aim to characterize early injecting careers and to identify the individual, social-structural and environmental factors that shape injecting initiation, early cessation of injecting, sustained injecting, and HIV risk behavior. Focusing on established injectors, we further aim to describe the individual, social-structural and environmental factors that shape cessation of and relapse into injecting, and associated morbidity and mortality. Our project involves the creation of a unique cohort, the Vancouver Drug Users Study (V-DUS, n = 1800), which involves adults who inject drugs and non-injecting street-involved drug-using youth. Participants provide behavioral information and biological specimens for testing, repository, and use by our team and other NIDA investigators. Members of our multidisciplinary team have more than two decades of experience conducting NIDA-funded cohort-based research, most recently through studies of IDU participating in the Vancouver Injection Drug Users Study (VIDUS), which is one of the longest-standing IDU cohort studies in the world, and street-involved drug-using youth participating in the At- Risk Youth Study (ARYS). In order to take advantage of considerable efficiencies, both academic and financial, we propose merging the ARYS and VIDUS cohorts into the Vancouver Drug Users Study (V-DUS), enabling a critical additional five years of investigation into the natural history f injection drug use. Vancouver is ideally suited for the proposed study for several reasons. The city was home to one of the most explosive HIV epidemics ever documented among IDU, and Vancouver is a port of entry for illicit drugs and is now experiencing a PO misuse epidemic. Further, under the province of British Columbia's universal healthcare plan, we are able to link cohort data to various administrative databases, permitting assessments of barriers to care that are free of the confounding effects of medical insurance schemes, and our established multidisciplinary team and other NIDA investigators use our cohort platform to undertake diverse work in the areas of clinical epidemiology, social, spatial, and basic science, as well as modeling
and cost-effectiveness studies. Lastly, Vancouver has been the site of the development of a range of innovative programs for IDU and therefore we plan to use this cohort infrastructure to build on our track record of evaluating highly innovative programs for IDU, as well as other naturally occurring events. Through this work, we aim to address several urgent global health challenges and inform the development of policies and interventions that seek to address illicit drug use.
描述:本申请提出了对注射吸毒的自然史(从开始到停止或死亡)的新研究,以及发病率和死亡率趋势的研究。我们建议在加拿大温哥华开展这项工作,那里的注射吸毒人数稳步增长。处方阿片剂 (PO) 滥用已成为日益受到关注的问题。因此,我们还寻求评估在海洛因市场活跃的环境中,处方阿片剂滥用对注射吸毒自然史的影响,包括 PO 使用对开始注射的影响。和我们还旨在描述早期注射职业的特征,并确定影响注射开始、早期停止注射、持续注射和艾滋病毒风险行为的个人、社会结构和环境因素。 ,我们进一步旨在描述影响注射戒断和复发的个人、社会结构和环境因素,以及相关的发病率和死亡率。我们的项目涉及创建一个独特的队列,即温哥华药物。用户研究(V-DUS,n = 1800),涉及注射毒品的成年人和非注射街头吸毒青少年,参与者提供行为信息和生物样本,供我们的团队和其他 NIDA 测试、存储和使用。我们的多学科团队成员拥有二十多年进行 NIDA 资助的队列研究的经验,最近通过参与温哥华注射吸毒者研究 (VIDUS) 的注射吸毒者研究。世界上历史最悠久的注射吸毒者队列研究之一提出,为了充分利用学术和财务方面的显着效率,我们将参与危险青少年研究(ARYS)的街头吸毒青少年纳入其中。 ARYS 和 VIDUS 队列纳入温哥华吸毒者研究 (V-DUS),从而能够对注射毒品使用的自然历史进行关键的五年调查。出于多种原因,温哥华非常适合这项拟议的研究。到这是有记录以来注射吸毒者中最具爆炸性的艾滋病毒流行病之一,而温哥华是非法药物的入境口岸,目前正在经历 PO 滥用流行病。此外,根据不列颠哥伦比亚省的全民医疗保健计划,我们能够将队列数据联系起来。各种行政数据库,允许不受医疗保险计划混杂影响的护理障碍,我们建立的多学科团队和其他 NIDA 研究人员使用我们的队列平台开展临床流行病学、社会、空间等领域的评估工作, 和基础科学以及建模
最后,温哥华是一系列注射吸毒者创新项目的开发地,因此我们计划利用这一群体基础设施来建立我们评估注射吸毒者高度创新项目的记录。通过这项工作,我们旨在解决一些紧迫的全球健康挑战,并为制定旨在解决非法药物使用问题的政策和干预措施提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas Kerr其他文献
Thomas Kerr的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas Kerr', 18)}}的其他基金
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the opioid epidemic
针对阿片类药物流行病的创新和综合应对措施的实施和有效性的民族流行病学研究
- 批准号:
9910376 - 财政年份:2017
- 资助金额:
$ 9.46万 - 项目类别:
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the opioid epidemic
针对阿片类药物流行病的创新和综合应对措施的实施和有效性的民族流行病学研究
- 批准号:
9365371 - 财政年份:2017
- 资助金额:
$ 9.46万 - 项目类别:
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the evolving overdoseepidemic
针对不断发展的过量用药流行病的创新和全面应对措施的实施和有效性的民族流行病学研究
- 批准号:
10657246 - 财政年份:2017
- 资助金额:
$ 9.46万 - 项目类别:
Vancouver Drug Users Study: Evaluating the Natural History of Injection Drug Use
温哥华吸毒者研究:评估注射吸毒的自然史
- 批准号:
8833623 - 财政年份:2015
- 资助金额:
$ 9.46万 - 项目类别:
Vancouver Drug Users Study: Evaluating the Natural History of Injection Drug Use
温哥华吸毒者研究:评估注射吸毒的自然史
- 批准号:
9185294 - 财政年份:2015
- 资助金额:
$ 9.46万 - 项目类别:
Vancouver Drug Users Study: Evaluating the Natural History of Injection Drug Use
温哥华吸毒者研究:评估注射吸毒的自然史
- 批准号:
9002025 - 财政年份:2015
- 资助金额:
$ 9.46万 - 项目类别:
Evaluating the natural history of injection drug use
评估注射吸毒的自然史
- 批准号:
8899303 - 财政年份:2014
- 资助金额:
$ 9.46万 - 项目类别:
HIV Risk Environments among FSW and DU: A Longitudinal Ethno-Spatial Approach
FSW 和 DU 之间的 HIV 风险环境:纵向民族空间方法
- 批准号:
8791892 - 财政年份:2012
- 资助金额:
$ 9.46万 - 项目类别:
HIV Risk Environments among FSW and DU: A Longitudinal Ethno-Spatial Approach
FSW 和 DU 之间的 HIV 风险环境:纵向民族空间方法
- 批准号:
8604385 - 财政年份:2012
- 资助金额:
$ 9.46万 - 项目类别:
HIV Risk Environments among FSW and DU: A Longitudinal Ethno-Spatial Approach
FSW 和 DU 之间的 HIV 风险环境:纵向民族空间方法
- 批准号:
8262512 - 财政年份:2012
- 资助金额:
$ 9.46万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
ADELANTE: A Randomized Controlled Trial of an Intervention to Improve Engagement in Care for Latinos with HIV
ADELANTE:一项旨在提高拉丁裔艾滋病毒感染者护理参与度的干预措施的随机对照试验
- 批准号:
10757099 - 财政年份:2023
- 资助金额:
$ 9.46万 - 项目类别:
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
抗 HIV 和抗 COVID-19 药物和物质使用障碍的肝毒性机制
- 批准号:
10684434 - 财政年份:2023
- 资助金额:
$ 9.46万 - 项目类别:
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
艾滋病毒及相关感染治疗研究艾滋病临床试验小组
- 批准号:
10493539 - 财政年份:2022
- 资助金额:
$ 9.46万 - 项目类别:
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
使用多阶段优化策略 (MOST) 为 HIV 临床护理中的吸烟者优化具有成本效益、可持续且可扩展的戒烟方案
- 批准号:
10548592 - 财政年份:2022
- 资助金额:
$ 9.46万 - 项目类别:
Integration of Electronic SBI(RT) into an HIV Testing Program to Reduce Substance Use and HIV risk Behavior among MSM in Argentina
将电子 SBI(RT) 纳入 HIV 检测计划,以减少阿根廷 MSM 的药物使用和 HIV 风险行为
- 批准号:
10402058 - 财政年份:2022
- 资助金额:
$ 9.46万 - 项目类别: